Supply Chain Intelligence

Artiva Biotherapeutics, Inc. Supply Chain

ARTV supply chain intelligence for Artiva Biotherapeutics, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

ARTV ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

3Suppliers
2Customers
2Debt Items
20Related Chains

Artiva Biotherapeutics, Inc. Suppliers

TickerNameConfidenceEvidence
GC-CELL GC-CELL 90% In August 2020, the Company entered into a Research and Service Agreement with GC Cell in which GC Cell is to provide mutually agreed research services in support of the research and development of o…
BLACKBIRD-CLINICAL-INC BLACKBIRD-CLINICAL-INC 80% Under the terms of the Blackbird Services Agreement, Blackbird provides consulting services in connection with the Company's clinical trials, including study strategy, clinical operations and patient…
FATE Fate Therapeutics, Inc. 72% Reciprocal relationship from FATE graph: Reciprocal relationship from ARTV graph: Reciprocal relationship from FATE graph: Reciprocal relationship from ARTV graph: Reciprocal relationship from FATE g…

Artiva Biotherapeutics, Inc. Customers

TickerNameConfidenceEvidence
GC-CELL GC-CELL 80% Under the AB-205 Agreement, GC Cell agreed to reimburse the Company for direct costs incurred on behalf of GC Cell in accordance with the Development Plan under the AB-205 Agreement, provided that su…
FATE Fate Therapeutics, Inc. 72% Reciprocal relationship from FATE graph: Reciprocal relationship from ARTV graph: Reciprocal relationship from FATE graph: th the GDPR and relevant local legislation in EEA Member States and the UK m…

Artiva Biotherapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
ARTV-DEBT Debt stack $10.9M 90% Market cache reports total debt of $10.9M.
ARTV-DEBT-7861 Xbrl Convertible 90% xbrl convertible detail from xbrl 2024-12-31.

Artiva Biotherapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Artiva Biotherapeutics, Inc..

Artiva Biotherapeutics, Inc. Ownership

HolderNameConfidenceEvidence
ARTV-OWNER-RA-CAPITAL-MANAGEMENT-L-P RA CAPITAL MANAGEMENT, L.P. 90% 13F overlay lists RA CAPITAL MANAGEMENT, L.P. as top holder; 41 tracked holders.

Artiva Biotherapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
IPSC Century Therapeutics, Inc. 100.00 1 ['receiving']
UPB Upstream Bio, Inc. 100.00 2
GILD Gilead Sciences, Inc. 100.00 2
IMTX Immatics N.V. 100.00 2
KLRS Kalaris Therapeutics, Inc. 100.00 2
TKPHF Takeda Pharmaceutical Company Limited 100.00 2
CHRS Coherus Oncology, Inc. 100.00 2
TBPH Theravance Biopharma, Inc. 100.00 2
ALLO Allogene Therapeutics, Inc. 100.00 1 ['receiving']
FATE Fate Therapeutics, Inc. 100.00 2 ['customer', 'supplier']
AZN AstraZeneca PLC 100.00 2
CLYM Climb Bio, Inc. 100.00 2
EDSA Edesa Biotech, Inc. 100.00 2
ALNY Alnylam Pharmaceuticals, Inc. 100.00 2
ACET Adicet Bio, Inc. 100.00 2
BNTX BioNTech SE 100.00 2
CLLS Cellectis S.A. 100.00 2
GDTC CytoMed Therapeutics Limited 100.00 1 ['spend']
CELU Celularity Inc. 100.00 2
MYGN Myriad Genetics, Inc. 100.00 2
View ARTV supply chain intel →

Explore the full interactive supply chain map for Artiva Biotherapeutics, Inc..

Open ARTV supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map